Sale by Matthew Gline (CEO)
289,774 shares · @ $29.16 · $8,449,810
Roivant Sciences Ltd. Common Shares · PHARMACEUTICAL PREPARATIONS · Now $29.09
+3.3% in 7d after detection
Post-detection moves
1h
—
1d
+1.6%
3d
+0.4%
7d
+3.3%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS